Whereas morpholino-mediated ablation of Bag3 in zebrafish embryos led to severe heart failure and myopathic phenotypes, the knockout of Bag3 by CRISPR/Cas9 technology was not accompanied by phenotypic alterations in the developing embryo. The gene discussed is BAG3; the disease is heart failure.